Tolerization as a Rational Design Approach for Reducing the Immunogenicity of Biologics (Campath) by Adam | Oct 21, 2016
The ISPRI Toolkit Rapidly Screens Biologic Product Candidates for Immunogenic Potential Driven by T cell Epitope Content and Foreignness by Adam | Oct 21, 2016
